Cartesian Therapeutics
RNAC
#8958
Rank
A$0.28 B
Marketcap
A$9.28
Share price
4.24%
Change (1 day)
-17.25%
Change (1 year)

EPS for Cartesian Therapeutics (RNAC)

EPS in 2026 (TTM): A-$2.74

According to Cartesian Therapeutics's latest financial reports the company's current EPS (TTM) is A-$2.81. In 2021 the company made an earnings per share (EPS) of A-$10.88 an increase over its 2020 EPS that were of A-$31.27.

EPS history for Cartesian Therapeutics from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$2.74
2021A-$10.88-65.22%
2020A-$31.27-43.44%
2019A-$55.30-58.08%
2018A-$131.89-9.35%
2017A-$145.49-29.16%
2016A-$205.38